Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective Study

Table 1

Baseline characteristics of two groups.

Characteristics	TCM users (n = 261)	TCM nonusers (n = 260)	value
Age (years)			0.307
<40	164 (62.8)	152 (58.5)
≥40	97 (37.2)	108 (41.9)
Gender (n, %)			0.670
Male	167 (64.0)	171 (65.8)
Female	94 (36.0)	89 (34.2)
Duration of illness (n, %)			0.757
0∼5	62 (23.8)	70 (26.9)
5∼10	55 (52.1)	48 (18.5)
10∼15	59 (22.6)	62 (23.8)
15∼	85 (32.6)	80 (30.8)
Smoking history (n, %)			0.506
Yes	33 (12.6)	28 (10.8)
No	228 (87.4)	232 (89.2)
Drinking history (n, %)			0.487
Yes	45 (17.2)	39 (15.0)
No	216 (82.8)	221 (85.0)
Family history of CHB-related diseases (n, %)			0.549
Yes	96 (36.8)	101 (39.8)
No	165 (63.2)	159 (61.2)
HBeAg			0.749
Positive	153 (58.6)	156 (60.0)
Negative	108 (41.4)	104 (40.0)
HBV DNA level (copies/mL)			0.644
10^3∼10^4	39 (14.9)	35 (13.5)
10^4∼10^5	31 (11.9)	29 (11.2)
10^5∼10^6	34 (13.0)	46 (17.7)
10^6∼10^7	45 (17.2)	49 (18.8)
10^7	112 (42.9)	101 (38.8)
ALT (IU/ml ULN)			0.714
1∼2	48 (18.4)	54 (20.8)
2∼3	137 (52.5)	129 (49.6)
3∼	76 (29.1)	77 (29.6)